Chronic Myeloproliferative Disorders Completed Phase 1 Trials for Cilengitide (DB11890)

IndicationStatusPhase
DBCOND0028462 (Chronic Myeloproliferative Disorders)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00004258EMD 121974 in Treating Patients With Locally Advanced or Metastatic CancerTreatment